Altered intracellular calcium and phorbol 12,13-dibutyrate binding to intact platelets in young obese subjects

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 2, 1997, Pages 245-250

  Takaya, Junji ^a   Iwamoto, Yukihisa ^a   Higashino, Hirohiko ^a   Kino, Minoru ^a   Kobayashi, Tatsuharu ^a   Kobayashi, Yohnosuke ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031080701     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90146-3     Document Type: Article

References (32)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
2. Cooper DR, Konda TS, Standaert ML, Davis JS, Pollet RJ, Farese RV. Insulin increases membrane and cytosolic protein kinase C activity in BC3H-1 myocytes. J Biol Chem 1987;262: 3633-9.
3. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform bII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992;89:11059-63.
4. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258: 607-14.
5. Hachiya HL, Takayama S, White MF, King GL. Regulation of insulin receptor internalization in vascular endothelial cells by insulin and phorbol ester. J Biol Chem 1987;262: 6417-24.
6. 2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C. Biochem J 1988;255:309-18.
7. 2+ transport by cAMP and calmodulin-dependent phosphorylation. Biochem Biophys Acta 1987;930:401-9.
8. Hilton PJ. Cellular sodium transport in essential hypertension. N Engl J Med 1986;314:222-9.
9. 2+ transport in human platelets: kinetics of active transport and passive release. J Biol Chem 1986;261:3122-7.
10. Fauvel J, Chap H, Roques V, Levy-Toledano S, Douste-Blazy L. Biochemical characterization of plasma membranes and intracellular membranes isolated from human platelets using Percoll gradients. Biochim Biophys Acta 1986;856:155-64.
11. Fox JEB. The organization of platelet contractile protein. In: George JN, Nurden AT, Phillips DR, editors. Platelet membrane glycoproteins. New York: Plenum, 1985:237-98.
12. Eme P, Bolli P, Burgisser E, Bfihler FR. Correlation of platelet calcium with blood pressure. Effects of antihypertensive therapy. N Engl J Med 1984;310:1084-8.
13. Lechi A, Lechi C, Bonadonna G, et al. Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients. Hypertension 1987;9:230-5.
14. Inoguchi T, Xia Pu, Kunisaki M, Higashi S, Feener EP, King GL. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 1994;267:E369-79.
15. Ishizuka T, Cooper DR, Arnold T, et al. Downregulation of protein kinase C and insulin-stimulated 2-deoxyglucose uptake in rat adipocytes by phorbol esters, glucose, and insulin. Diabetes 1991;40:1274-81.
16. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
17. 2+. Biochem J 1991;278:411-5.
18. + antiport activation by endothelin in human skin fibroblasts. FEBS Lett 1989;256:38-42.
19. Van De G Werve, Zaninetti D, Lang U, Vallotton MB, Jeanrenaud B. Identification of a major defect in insulin-resistant tissues of genetically obese (fa/fa)rats: impaired protein kinase C. Diabetes 1987;36:310-4.
20. Modan M, Halkin H, Almog S, et al. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 1985;75:809-17.
21. Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA. Possible role of cytosolic free calcium concentration in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 1988;82:1848-52.
22. + exchange decreases the affinity of sodium sites. Kidney Int 1994;46:365-75.
23. + antiport in the development of hypertension and insulin resistance. J Am Soc Nephrol 1992;3:1049-63.
24. Mineda T. Studies on blood glucose, immunoreactive insulin (IRI) and connecting peptide immunoreactivity (CRP) during oral glucose tolerance tests in children. J Nippon Med Sch 1978;45:1-15.
25. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab 1986;62:1302-4.
26. Rocchini AP, Moorehead C, Katch V, Key J, Finta KM. Forearm resistance vessel abnormalities and insulin resistance in obese adolescents. Hypertension 1992;19:615-20.
27. Temple RC, Clark PMS, Nagi DK, Schneider AE, Yudkin JS, Hales CN. Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol 1990;32: 689-93.
28. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 1988;37:338-45.
29. Modan M, Halkin H, Almog S, et al. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 1985;75:809-17.
30. Salans LB, Cushman SW, Weismann RE. Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J Clin Invest 1973;52:929-41.
31. Pedersen O, Kahn CR, Kahn BB. Divergent regulation of the Glut1 and Glut4 glucose transporters in isolated adipocytes from Zucker rats. J Clin Invest 1992;89:1964-73.
32. Gardner JP, Cho JH, Skumick JH, et al. Blood pressure inversely correlates with thrombin-evoked calcium rise in platelets. Hypertension 1994;23(part 1):703-9.